Abstract
Glioma is one of the deadliest malignant brain tumors in adults worldwide. MicroRNA (miR) has been reported to be a pivotal regulator in human tumors. The aim of this study was to determine the expression, function, and mechanism of action of miR-1269a in glioma progression. The expression of miR-1269a was higher in both glioma cases reported in databases and glioma cell lines, and it was highly associated with poorer prognosis. Next, it was shown in vitro that mimic of miR-1269a could promote glioma progression and arrest apoptosis, whereas the inhibition of miR-1269a exhibited the opposite effects. In addition, miR-1269a was found to directly target ATRX chromatin remodeler by a dual-luciferase reporter assay. Moreover, ATRX overexpression could reverse the suppressive effects of miR-1269a on proliferation and apoptosis in vitro. In vivo subcutaneous xenograft tumor assay was also performed to confirm the phenotypes and molecular mechanism involved. Taking the findings together, our study implies that the miR-1269a/ATRX axis is a novel therapeutic target of glioma.
References
Aug 22, 2001·In Vitro Cellular & Developmental Biology. Animal·B KumarK N Prasad
Aug 30, 2005·Molecular & Cellular Proteomics : MCP·Mathias UhlénFredrik Pontén
Mar 22, 2008·Neuro-oncology·Kathleen R LambornUNKNOWN North American Brain Tumor Consortium
Aug 20, 2014·Genome Research·Zhao-Shi BaoTao Jiang
Dec 5, 2014·BMC Cancer·Xue-Wei YangPing Xue
Apr 16, 2015·Nature Communications·Pengcheng BuXiling Shen
Jun 11, 2015·The New England Journal of Medicine·Jeanette E Eckel-PassowRobert B Jenkins
Mar 5, 2016·Science Translational Medicine·Carl KoschmannMaria G Castro
Mar 9, 2017·Current Neurology and Neuroscience Reports·Michael KarsyHoward Colman
Mar 16, 2017·Scientific Data·Zheng ZhaoTao Jiang
Oct 17, 2017·Frontiers in Oncology·Pravanya NandakumarSunit Das
Dec 2, 2017·Nucleic Acids Research·Tomas TokarIgor Jurisica
Mar 15, 2018·Nature Communications·Carla DanussiJason T Huse
Apr 6, 2018·OncoTargets and Therapy·Min BaoZongren Wan
Apr 19, 2018·Critical Reviews in Clinical Laboratory Sciences·Ivana Jovčevska
Jun 12, 2018·Expert Opinion on Therapeutic Targets·Santiago HaaseMaria G Castro
Jun 28, 2018·Cancer Science·Qian ZhouWeiping Li
Aug 1, 2018·Lancet·Sarah LapointeNicholas A Butowski
Feb 6, 2019·Cancers·Denise FabianJoshua D Palmer
Sep 11, 2019·Nucleic Acids Research·Yuhao Chen, Xiaowei Wang
Nov 27, 2019·Cancer Cell International·Wen-Li LiuGuang-Hui Wang
Mar 21, 2020·Theranostics·Bo HanTao Jiang
Apr 5, 2020·Cancers·Zhen Dong, Hongjuan Cui